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Edited by Varda RotterAbstract It is clear that G1–S phase control is exerted after the
mouse embryo implants into the uterus 4.5 days after fertiliza-
tion (E4.5); null mutants of genes that control cell cycle commit-
ment such as max, rb (retinoblastoma), and dp1 are embryonic
lethal after implantation with proliferation phenotypes. But, a
number of studies of genes mediating proliferation control in
the embryo after fertilization-implantation have yielded confus-
ing results. In order to understand when embryos might ﬁrst ex-
ert G1–S phase regulatory control, we assayed preimplantation
mouse embryos for the acquisition of expression of mRNA, pro-
tein, and phospho-protein for max, Rb, and DP-1, and for the
proliferation-promoting phospho-protein forms of mycC (thr58/
ser62) and Rb (ser795). The key ﬁndings are that: (1) DP-1 pro-
tein was present in the nucleus as early as the four-cell stage on-
wards, (2) max protein was in the nucleus, suggesting function
from the four-cell stage onwards, (3) both mycC and Rb all form
protein was present at increasing quantities in the cytoplasm
from the 2 cell and 4/8 cell stage, respectively, (4) the phosphor-
ylated form of mycC phospho was present in the nucleus at high
levels from the two-cell stage through blastocyst-stage, and (5)
the phosphorylated form of Rb was detected at low levels in
the two-cell stage embryo and was highly expressed at the 4/8-
cell stage through the blastocyst stage. Taken together, these
data suggest that activation of mycC phospho/max dimer pairs,
(E2F)/DP-1 dimer pairs, and repression of Rb inhibition of cell
cycle progression via phosphorylation at ser795 occurs at the
earliest stages of embryonic development. In addition, the pres-
ence of max, mycC phospho, DP-1, and Rb phospho in the nuclei
of embryonic and placental lineage cells in the blastocyst and in
trophoblast stem cells suggests that a similar type of cell cycle
regulation is present throughout preimplantation development
and in both embryonic and extra-embryonic cell lineages.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Several proliferation-controlling genes, including retinoblas-
toma (Rb) [64], DP-1 [33], and max [56], have been shown to
be essential for life in mammalian embryos after implantation
into the uterus (implantation occurs 4.5 days after fertilization;
E4.5). The embryonic lethality in these three null mutants was
caused by failure of placental (trophoblast cell) development
and/or embryonic proliferation.
Proliferation control is exerted in TSC in the embryo at the
ﬁfth cell division before implantation at E3.5 [9,58]. These data
suggest that proliferation control is essential for placental
development before and after implantation. It is not clear if
the essential post-implantation role of retinoblastoma, DP-1,
and max also extends to preimplantation development. Cer-
tainly, max and retinoblastoma mRNA are expressed in the
oocyte and may delay the lethal eﬀects in the max and retino-
blastoma null embryos [30,56,64] after the embryonic genome
is activated at the two-cell stage [27]. It is important to deter-
mine the acquisition of expression of DP-1, and phosphoryla-
tion state of the retinoblastoma, and mycC gene products to
understand when the embryo might ﬁrst use these gene prod-
ucts in proliferation control.
Earlier studies on retinoblastoma in preimplantation mouse
embryos suggested a repressive role in S phase control, but
also suggested that this did not occur until the blastocyst stage
[30]. Rb suppresses cell cycle progression from G1 to S phase
[18] until Rb is phosphorylated on several phosphorylation
sites in the C terminus, most importantly ser795. Ser795 phos-
phorylation occurs through multiple mechanisms, including
CDK4/cyclin [19] and MAPK [10]. Upon phosphorylation at
the ser795, Rb dissociates from E2F transcription factors that
it suppresses [32]. There are six E2F genes that act as transcrip-
tion factors that activate genes required for S phase [34,53].
E2F-1, -3, -5, and -6 are expressed as maternal mRNA in the
oocyte and in the early mouse embryo [43]. All the E2F tran-
scription factors require the ubiquitously expressed dimer part-
ner DP-1 in order to activate transcription [34,53], but the
expression of DP-1 has not been studied in the preimplanta-
tion embryo. These data suggest that E2F may be redundant
in function but that the dp1 null mutant dominantly inactivatesblished by Elsevier B.V. All rights reserved.
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synthesis and lethality soon after implantation.
MycC, MycB, and MycL are detected in the preimplantation
mouse embryo but no single null mutant is lethal at this stage
or early after implantation [15,42]. MAPK phosphorylates
MycC directly at thr58/ser62 [23] indirectly by inducing cyclin
and CDK [11,54] and this leads to mitosis [47,52]. MAPK in-
duces transcription and translation of cyclins during the cell
cycle and these activate constitutive cyclin-dependent kinases
(CDK) and progression to S phase [16,40]. MycC has been
associated with embryo progression and/or proliferation
[35,45], but the mycC null mutant is not lethal before implan-
tation, suggesting redundancy of myc family proteins. The se-
ven myc family members require a ubiquitously expressed
dimer partner named max, and max is a lethal null mutant
after implantation [56]. As with DP-1, the max null mutant
is phenotypically dominant over the myc family that requires
max function.
In this study, we show that Rb and mycC phospho-proteins
and DP-1 and max proteins are detected by the second–third
cell division (2–4 cell stage embryos) and are found in the nu-
cleus, where their proliferative control would be exercised.2. Materials and methods
2.1. Reagents
Amplitaq DNA polymerase was purchased from Perkin–Elmer Ce-
tus (Norwalk, CT). Moloney murine leukemia virus (MMLV) reverse
transcriptase and Superscript MMLV reverse transcriptase were ob-
tained from Gibco/BRL. Polymerase chain reaction (PCR) oligonucle-
otides were obtained from Pharmacia (Piscataway, NJ). Radioisotopes
were obtained from New England Nuclear (Boston, MA). Agarose was
from FMC (Rockland, ME). The antibodies used were: MycC all
forms (SC788), MycC phospho thr58/ser62 (CS9401, SC8000R), max
all forms (SC197, SC765), retinoblastoma all forms (MS-595, Lab vi-
sion, SC7905), retinoblastoma phospho ser795 (CS9301, SC7986R),
and DP-1 (SC610). All of the antibodies were from Santa Cruz (SC
preﬁxes) Biotechnology (Santa Cruz, CA) or Cell Signaling Technol-
ogy (CS preﬁxes, Beverly, MA). Hoechst 33258 was purchased from
Sigma Chemical (St. Louis, MO). All other chemicals were obtained
from Sigma Chemical (St. Louis, MO).2.2. Mouse embryos and cell culture
Mouse strains MF-1 (Harlan Sprague–Dawley, Indianapolis, IN)
were crossed with B6SJL1/J (Jackson Laboratories, Bar Harbor,
ME) to produce F1 embryos via superovulation. RT-PCR was per-
formed as previously described [50]. Embryos were used immediately.
Mouse trophoblast stem cells (TSC, [58] and large SV40 large T trans-
formed human trophoblast cells (HTR, [20] were cultured as described.
Human prostate cancer cells (PC3)[17] and human pancreatic ductal
adenocarcinoma cells (BXPC3) [26] were obtained from American
Type Culture Collection (ATCC) (Rockville, MD). Cells were grown
in cell culture medium RPMI 1640 supplemented with 10% fetal bovine
serum, 2 mM L-glutamine, penicillin (100 IU/mL) and streptomycin
(100 lg/mL) in 95% air and 5% CO2.2.3. Immunocytochemistry and Western blot analysis
Immunocytochemistry was used to test whether signal transduction
proteins were present. The position of these signal transduction gene
products was determined to be in the cytoplasm and/or nucleus of
embryonic and trophoblast cells in preimplantation mouse embryos
and TSC. Immunocytochemistry was performed as follows: cells or
embryos were ﬁxed for 30 min with 2% fresh paraformaldehyde,
quenched with 0.1 M glycine, permeabilized with 0.1% Triton-X
100, washed three times, incubated with ﬁrst antibody for 1 h,
washed three times, incubated with biotin-coupled anti-ﬁrst antibody
for 1 h, washed three times, incubated with streptavidin ﬂuor for 1 h,incubated with Hoechst stain, washed three times and photographed
using a Leica DME IR2 automated epiﬂuorescence microscope with
a Retiga 1350 Ex cooled CCD. All stages of embryos were exposed
for an equal time for each antibody to facilitate comparisons of
expression levels during preimplantation development. Photographs
were analyzed using Photodex CPIC and C-Imaging Simple PCI
intensity analysis software and formatted for presentation using
Adobe Photoshop. All ﬂuorescence photos were handled and ana-
lyzed in the same way. All experiments were repeated at least twice
with similar results.
Trophoblast stem cells (TSC) were isolated from E3.5 embryos or
E6.5 extraembryonic ectoderm and provided as a gift by Dr. J. Rossant
[9,58].
TSC or HTR were grown to 70–80% conﬂuency in order to obtain
cell lysates for Western blotting. Cells were washed twice with ice-cold
PBS. Western blotting was performed using whole-cell extracts, which
were prepared by incubating the cells in cold cell lysis buﬀer (20 mM
Tris–HCl, 150 mM NaCl, 1 mM EGTA, 1% Triton, 2.5 mM sodium
pyrophosphate, 1 mM b-glycero-phosphate, 1 mM Na3VO4, 1 lg/ml
leupeptin, and 1 mM PMSF; Cell Signaling) plus Proteinase Inhibitor
Cocktail (PIC1, Sigma) and PIC2 (Sigma) for 20 min. The lysates were
centrifuged at 10 000 · g for 10 min and the supernatant was stored at
80 C. The proteins in 20 lg of whole-cell extracts were separated by
electrophoresis on a 10% SDS–PAGE gel using a Hoefer Mighty Small
II SE 250 apparatus and then transferred to ECL Hybond nitrocellu-
lose membranes (Amersham) at 15 V for 30 min using a Bio-Rad Semi-
dry Transfer Cell. The membranes were blocked overnight with 5%
non-fat milk in Tris buﬀered saline-Tween 20 (TTBS) and blotted with
the speciﬁed primary antibodies for 1 h followed by 3 washes in TTBS.
They were then incubated in horseradish peroxidase (HRP) conjugated
secondary antibody for 1 h followed by extensive wash with TTBS. Pri-
mary and secondary antibodies were diluted in 1% non-fat milk/TTBS.
The protein bands were visualized using enhanced chemiluminescence
(ECL) assay system (Amersham).
2.4. RNA isolation and RT-PCR
AmpliTaq Gold DNA polymerase was purchased from Applied Bio-
systems. Restriction enzymes were purchased from New England
BioLabs and Gibco/BRL. SUPERSCRIPT Reverse Transcriptase
was obtained from Invitrogen Life Technologies. Polymerase chain
reaction primers were designed using the GeneFisher software (Biele-
feld University Bioinformatics Server). PCR oligonucleotides were ob-
tained from Integrated DNA Technologies.
Speciﬁc stage mouse embryos were ﬂushed, washed though 6 drops
of M2 media (Sigma) and saved in RLT buﬀer (from the Qiagen
RNeasy Mini Kit) at 80 C before use. Qiagen RNeasy Mini Kit
(50) was used to prepare total RNA from 200 embryos containing
10 lg of 16S-and 23S-ribosomal RNA (Roche) according to the man-
ufacturers instructions. Yields of RNA were based on carrier amount
and ranged from 35% to 80%. RNA used for positive controls was iso-
lated from mouse organs. The concentration of RNA was determined
by measurement of absorbance at 260 nm. RT-PCR was performed
essentially as described previously [48,49,51] with the use of the oligo-
nucleotide primers shown in Table 1. Brieﬂy, RNA was reverse-tran-
scribed with 200 units of SUPERSCRIPT Reverse Transcriptase,
0.5 mg of 12- to 18-mer oligo(dT) (Invitrogen Life Technologies) in
a 20 ll mixture. Reaction mixtures were heated at 37 for an hour fol-
lowed by 95 for 3 min; 60 additional units of buﬀered SUPER-
SCRIPT Reverse Transcriptase were added and the reaction
mixture was reincubated at 42 degree for another hour. The proportion
of the reaction mixture that was equivalent to 20 embryos was added
to sequence-speciﬁc primed PCR mixture in a buﬀer containing 10 mM
Tris–HCl (pH 8.3), 600 lM each dNTP, and MgCl2 range from 3 mM
to 7.5 mM in a 50 ll reaction mixture [21]. 1 lg of organ total RNA
was reverse-transcribed and 1 ll reaction mixture (or a dilution series
of it) was ampliﬁed by PCR for 40 cycles on an Eppendorf Mastercy-
cler/Mastercycler gradient PCR machine. The PCR fragments were
separated on a 4% agarose gel (BMA, SeaKem LE agarose) containing
ethidium bromide. Gels were photographed with a Polaroid MP-4
camera and negative images were reversed for clarity of presentation.
Fragments were veriﬁed by size and restriction enzyme mapping [7].
For restriction enzyme analysis, the fragments were precipitated with
ammonium acetate directly from the PCR mixture, washed twice with
70% ethanol and digested according to the restriction enzyme manu-
facturers instructions.
Table 1
Oligonucleotide primers used for RT-PCR
Accession Gene Primer sequence







M_262391 RB 5 0AATAGAGGCACTCCCTTCAC 417 10 pg spleen BclI, HinfI
3 0ATCTCGAAGCAGGATCTCTG
NM_009361 DP-1 5 0TTACTCAACCCGTAGACCCCTCT 410 10 pg spleen AccI, HindIII
3 0CACCTGGGTGCTGGACATCG
aPoint in a ten-fold dilution series of RT-PCR where last signal is characteristically seen.
400 Y. Xie et al. / FEBS Letters 579 (2005) 398–4082.5. Generation of microarray data
The generation and analysis of microarray data have been previ-
ously described in detail [59]. Brieﬂy, 35 total RNA preparations from
12 oocyte/embryo stages (2–4 preparations for each stage) with TRIzol
were supplemented by linear polyacrylamide and carrier tRNA [60].
For each replicate, 10 ng total RNA was ampliﬁed using a modiﬁed
two-round Eberwine protocol [60]. 10 lg of RNA was hybridized to
Murine Genome U74Av2 GeneChip following Aﬀymetrix instructions.
Analyses of the raw data were performed with dChip (www.dchip.org).3. Results
3.1. Preimplantation mouse embryos and unfertilized eggs were
tested for expression of a DP-1 and Rb mRNA by RT-PCR
mRNA transcripts for DP-1 and Rb were detected in unfer-
tilized eggs, and also in zygotes from morula through blasto-
cyst (Fig. 1). DP-1 and Rb were expressed abundantly (>50
ng of positive control) in unfertilized eggs, decreased at the late
2-cell stage, and then increased through the blastocyst stage.
The Rb expression levels were in agreement with a previous re-
port in a diﬀerent strain of mice [30], suggesting that this is a
common expression pattern in all mice. This initial increase
in PCR band density corresponds to zygotic genomic
activation.
The expression of the housekeeping gene GAPDH served as
an internal control to detect DNA contamination and to nor-
malize the amount of cDNA. RT-PCR performed on RNase-
treated embryo and RNA only controls in the PCR were doneFig. 1. mRNA transcripts for two post-implantation null lethal genes are exp
eggs as detected by RT-PCR. The bands on the left represent mRNA express
those on the right represent the dilution series of positive control. mRNA tran
control) in the unfertilized eggs, decrease at zygotic genome activation at E1.5
equivalent to 12 ± 2 embryos that are equivalent to 4200 pg (UE), 840 pg (E1
preparation of embryos was ﬁrst normalized for an equal amount of GAPDH
dilutions beginning at the left with 50 ng of whole RNA. The sources of cofor every RT and were always negative (data not shown).
GAPDH mRNA was expressed at all stages of preimplanta-
tion mouse embryos. Fragments were found to be of the cor-
rect size and the restriction digests produced the correct-sized
bands with two restriction enzymes each. Each analysis was re-
peated twice with similar results. The threshold for signal
detection was between 1 and 100 pg. Since 10 pg is equal to
the RNA in one ﬁbroblast, the data suggest that the primer
sensitivity is suﬃcient to detect mRNA in any stage of embryo.
Information on primers design, restriction enzyme application
and PCR amplimer validations are given in Table 1.3.2. Preimplantation mouse embryos and unfertilized eggs were
tested for expression of a DP-1, myc/max, and Rb mRNA
by cDNA array
We also performed tests on myc and Rb family members,
and max and DP-1 mRNA levels using Aﬀymetrix cDNA ar-
rays. Twelve oocyte and preimplantation embryo stages were
tested for 2–4 replicates each as previously reported [59]. The
oocyte and embryo preparations were repeated 2–4 times for
each stage for a total of 35 preparations. Reproducibility of
samples from single time stages was assessed by calculating
Pearson Correlation (r value), which ranges from 0.948 to
0.996 with a median of 0.977. MycC was expressed only after
zygotic genome activation at the two-cell stage (Fig. 2A),
whereas three other Myc family members were detected in oo-
cytes as well as embryos. MycN was expressed at the highestressed in similar patterns in preimplantation embryos and unfertilized
ion in unfertilized eggs (UE = E0.5) or preimplantation embryos, while
scripts for DP-1 and Rb are expressed at high levels (>50 ng of positive
(2-cell stage), and then increase in blastocyst stage (E3.5). Each lane is
.5), and 18 ng (E3.5) or unfertilized eggs or embryos as indicated. Each
mRNA in the RT-PCR. Control RNA is shown in a series of 10-fold
ntrol RNA and RT-PCR products sizes are shown in table.
Fig. 2. Detection of transcription of growth control genes in oocytes
and preimplantation mouse embryos by microarray. The line graphs
show the temporal patterns of transcription for myc family genes (A),
Max (B), Dp-1 (C), Rb and Rb-like genes (D). Expression levels are
calculated from signal intensity on the chips and are arbitrary.
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stage. The obligate heterodimer partner for the myc family
members, max, was detected at very high levels in the oocyte
and high levels in the embryo (Fig. 2B). DP-1, the obligate
heterodimer partner of the E2F family, was also detected at
very high levels in oocytes and embryos (Fig. 2C). The three
Rb family members were expressed in oocytes and embryos
(Fig. 2D), but p130 was expressed at very low-background
levels and p110 (Rb) was expressed at higher levels in the
blastocyst.
3.3. Two post-implantation null lethal genes and one dimeric
partner of a post-implantation null lethal were detected as
proteins or phospho-proteins in the ﬁrst two cleavage
divisions
In order to assay for the pre-lethal function of null lethal
proliferation-promoting gene products, we tested when and
where a set of three proteins are present, and also tested
the activated status of two of these proteins in preimplanta-
tion embryos and TSC. These protein products are thought
to be important functional components of receptor tyrosine
kinase-to-MAPK enzyme signaling and the location where
these proteins function is in the nucleus. We detected the
expression of all form and phospho form of these proteins
in late 2-cell (E1.5), 4/8-cell (E2.5), and early blastocyst
(E3.5) embryos ex vivo and TSC. MycC phospho was ﬁrst
detected in the nucleus at the two-cell stage (Fig. 3) and
the all forms antibody detected protein in the cytoplasm
(Fig. 4A). All stages of embryos were exposed for an equal
time for each antibody to facilitate comparisons of expression
levels during preimplantation development. MycC phospho
and all forms proteins were also detected in the nucleus
and cytoplasm and nucleus, respectively, of TSC, where the
correct sized 49 and 67 kDa bands [1,35], respectively, were
detected after SDS–PAGE and Western blot analysis. MycC,
mycB, and mycL have been reported in preimplantation
mouse embryos [15] and could cross react with mycC anti-
bodies. MycL has been reported to have sizes of 60 and 66
kDa similar to mycC (67 and 49 kDa), that could cross react
with mycC [14], however, mycB has a reported size of 26 kDa
[2] and would not be mistaken for mycC.
Since the mycC all forms was anticipated to be in the nu-
cleus constitutively, we tested the antibody we used in two
other somatic cell types (pancreas and prostate), where we de-
tected MycC all forms in the nucleus as previously reported
[Fig. 4G-I, in pancreatic BXPC3 shown, and prostate PC3
not shown [13,54]]. Three myc family members are known
to cycle between the cytoplasm and the nucleus; MondoA,
Mad4, and Mlx [4,5,22,28,63]. However, if these myc family
members cross-reacted with mycC all forms antibody, they
would produce 20–35 kDa bands in Westerns of TSC and
HTR, not the 67 dDa that is correct for mycC all forms
and that we detected. Therefore, in TSC and embryos it is
most likely that all forms MycC antibody is detecting only
its cognate antigen and this antigen is primarily in the cyto-
plasm. These data suggest that the import of mycC or its
accumulation in the nucleus is diﬀerent in embryos and
TSC, compared with somatic cells as previously reported
[24,54], and may be like MondoA, Mad4, and Mlx in other
somatic cell types and like mycC all forms in the frog embryo
in the cleavage divisions immediately after fertilization [25]
when mycC is also mostly cytoplasmic.Max protein, the obligate heterodimer partner for mycC
phospho, is constitutively present in the nucleus of preimplan-
tation blastocysts and TSC (Fig. 5). These data suggest that
Fig. 3. MycC phospho is expressed in preimplantation mouse embryos and TSC. E1.5, E2.5, and E3.5 embryos and TSC are ﬁxed and developed by
immunocytochemical means for mycC phospho. Micrographs show mycC phospho in E1.5 (late 2-cell), E2.5 (late 8-cell), and E3.5 (early blastocyst)
embryos (A), and respective propidium iodide-stained nuclei (B) and after merging (C). The E3.5 embryo in the upper right corner is a no antibody
control. TSC are stained for mycC phospho are shown in (D), respective Hoechst-stained nuclei (E), and after merging (F). Arrows show the protein
in the nuclei (A, D) and arrowheads show the nuclei in same cell (B, C, E, F). In some areas, the red intensity is very strong because many TSC pile
up. Two arrows in the blastocyst in A show trophoblast cells that would be presumptive TSC adjacent to the ICM and a diﬀerentiating trophoblast
cell away from the ICM. Note that the arrow on the right side of D, E, F shows a mitotic cell. Inset shows the correct-sized band for mycC phospho
at 49 kDa in a Western blot developed from TSC lysates. A minor unidentiﬁed band at 90 kDa has been previously reported.
Fig. 4. MycC all forms is expressed in preimplantation mouse embryos and TSC. E1.5, E2.5, and E3.5 embryos and TSC are ﬁxed and developed by
immunocytochemical means for mycC all forms. Micrographs show mycC all forms in E1.5 (late 2-cell), E2.5 (late 8-cell), and E3.5 (early blastocyst)
embryos (A), and respective propidium iodide-stained nuclei (B) and after merging (C). The E3.5 embryo in the upper right corner is a no antibody
control. TSC stained for mycC all forms are shown in (D), respective Hoechst-stained nuclei (E), and after merging (F). Arrows show the protein in
the nuclei (A, D) and arrowheads show the nuclei in the same cell (B, C, E, F). Two arrows in the blastocyst in A show trophoblast cells that would be
presumptive TSC adjacent to the ICM and a diﬀerentiating trophoblast cell away from the ICM. In some areas, the red intensity is very strong
because many TSC pile up. Micrographs show mycC all forms in BXPC3 somatic pancreatic cells in (G), Hoechst-stained nuclei (H) and after
merging (I). Arrows show the protein in the nuclei (G) and arrowheads show the nuclei in same cell (H, I). No antibody controls are shown in Fig. 2.
Inset shows the correct-sized band for mycC all forms at 67 kDa in a Western blot developed from TSC lysates.
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Fig. 5. Max all forms is expressed in preimplantation mouse embryos and TSC. E1.5, E2.5, and E3.5 embryos and TSC are ﬁxed and developed by
immunocytochemical means for Max all forms. Micrographs show Max all forms in E1.5 (late 2-cell), E2.5 (late 8-cell), and E3.5 (early blastocyst)
embryos (A), respective propidium iodide-stained nuclei (B) and after merging (C). The E3.5 embryo in the upper right corner is a no antibody
control. TSC are stained for Max all forms are shown in (D), respective Hoechst-stained nuclei (E), and after merging (F). Arrows show the protein
in the nuclei (A, D) and arrowheads show the nuclei in the same cell (B, C, E, F). In some areas, the red intensity is very strong because many TSC
pile up.
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second cell cycle in preimplantation mouse embryos.
We next tested for the expression of Rb phospho and all
form proteins in cells in 2-cell (E1.5), 4/8-cell (E2.5), and blas-
tocyst (E3.5) embryos ex vivo and TSC. Like MycC phospho,
Rb phospho was ﬁrst detected in the nucleus at two-cell stage
(Fig. 6 compared with Fig. 3), but at a lower level of intensity.
All forms antibody detected low levels of protein in the cyto-
plasm and nucleus at the two-cell stage (Fig. 7). Rb phospho
and all forms proteins were also detected in the nucleus and
nucleus and cytoplasm, respectively, of TSC, where the cor-
rectly sized 110 kDa bands [18,46] were detected after SDS–
PAGE and Western blot analysis. It is not clear if the p110
Rb antibody used could cross-react with p107 in the Western,
but compared with p110 Rb very little p107 mRNA is present
at the blastocyst stage when a large increase in Rb is detected
in the blastocyst (compare Figs. 2D and 7). By the 4–8-cell
stage, and through the morula-blastocyst stage, the phospho
Rb was more intense than the two-cell stage and the nucleus.
A steady increase in intensity of Rb all forms was observed
from the 2-cell stage onwards. However, as previously re-
ported, there is a large increase in Rb all forms at the blasto-
cyst stage [30]. All stages of embryos were exposed for an
equal time to facilitate comparisons of expression levels during
preimplantation development. The proteins related to retino-
blastoma have molecular weights of 107 [36] and 130 kDa
[8,39]. These data suggest that Rb may be regulating progres-
sion to S phase as early as the second cell cycle in preimplan-
tation mouse embryos.
Since E2F/DP-1 is downstream of Rb repression, and both
Rb and DP-1 are post-implantation null placental lethals, we
tested for the onset and location of DP-1 expression in late
2-cell (E1.5), 4/8-cell (E2.5), and early blastocyst (E3.5) em-
bryos ex vivo. DP-1 was expressed in the nucleus from the
two-cell stage through the early blastocyst (Fig. 8). These datasuggest that E2F/DP-1 dimer pairs may activate S phase spe-
ciﬁc genes at the earliest stages of embryonic development.4. Discussion
We report here the novel ﬁndings that Rb and mycC pro-
teins are phosphorylated at amino acid residues that suggest
proliferation-generating activity, by the 2-cell stage embryo.
Their detection in the nucleus also suggests activity in prolifer-
ation control. In addition, DP-1, a necessary heterodimer pair
partner of E2F transcription factors, and max, a necessary
heterodimer partner of myc transcription factors, is detected
in the nucleus by the 4-cell stage and is constitutively expressed
in preimplantation development. Of the proteins studied,
mycC showed nuclear accumulation only in the phosphory-
lated form, not the all forms. This pattern suggests that a small
subpopulation of mycC all forms is phosphorylated and then
accumulates in the nucleus. Taken together, these data suggest
that elements in the pathways are present to activate myc/max
and derepress E2F/DP-1 by inactivating Rb, and are in the
correct cellular location to mediate proliferation control early
during embryonic development.
Previous results for mycC RNA expression were in conﬂict.
One report found no (sub-threshold) maternal expression in
oocytes, higher levels at the 4 cell-stage through morula, and
low (sub-threshold) expression at the blastocyst stage [15]. An-
other study reported low expression in the oocyte and increas-
ing expression through the blastocyst stage [42]. Our results
suggest that mycC was zygotic, not maternal, and increased
through morula with lower, but signiﬁcant expression at the
blastocyst-stage. Cause-and-eﬀect and correlative studies sug-
gested that mycC could have function at the 8-cell/morula
stage and that mitogenic stimuli of blastocysts could induce
mycC mRNA and accumulation of a 62 kDa protein that
Fig. 6. Rb phospho is expressed in preimplantation mouse embryos and TSC. E1.5, E2.5, and E3.5 embryos and TSC are ﬁxed and developed by
immunocytochemical means for Rb phospho. Micrographs show Rb phospho in E1.5 (late 2-cell), E2.5 (late 8-cell), and E3.5 (early blastocyst)
embryos (A), and respective propidium iodide-stained nuclei (B) and after merging (C). The E3.5 embryo in the lower right corner is a no antibody
control. TSC are stained for Rb phospho are shown in (D), respective Hoechst-stained nuclei (E), and after merging (F). Arrows show the protein in
the nuclei (A, D) and arrowheads show the nuclei in the same cell (B, C, E, F). Two arrows in the blastocyst in A show trophoblast cells that would be
presumptive TSC adjacent to the ICM and a diﬀerentiating trophoblast cell away from the ICM. Note that the arrow on the right side of D, E, F
shows a mitotic cell. In some areas, the red intensity is very strong because many TSC pile up. Inset shows the correct sized band for Rb phospho at
110 kDa in a Western blot developed from TSC lysates.
Fig. 7. Rb all forms is expressed in preimplantation mouse embryos and TSC. E1.5, E2.5, and E3.5 embryos and TSC are ﬁxed and developed by
immunocytochemical means for mycC all forms. Micrographs show Rb all forms in E1.5 (late 2-cell), E2.5 (late 8-cell), and E3.5 (early blastocyst)
embryos (A), respective propidium iodide-stained nuclei (B) and after merging (C). The E3.5 embryo in the lower right corner is a no antibody
control. TSC stained for Rb all forms are shown in (D), respective Hoechst-stained nuclei (E), and after merging (F). Arrows show the protein in the
nuclei (A, D) and arrowheads show the nuclei in the same cell (B, C, E, F). Two arrows in the blastocyst in A show trophoblast cells that would be
presumptive TSC adjacent to the ICM and a diﬀerentiating trophoblast cell away from the ICM. Note that the arrow on the left side of D, E, F shows
a mitotic cell. In some areas, the red intensity is very strong because many TSC pile up. No antibody controls are shown in Fig. 2.
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Fig. 8. DP-1 all forms is expressed in cells in the preimplantation mouse embryos and TSC. E3.5 embryos and TSC are ﬁxed and developed by
immunocytochemical means for DP-1 all forms Micrographs show DP-1 all forms, in E1.5 (late 2-cell), E2.5 (late 8-cell), and E3.5 (early blastocyst)
embryos (A), respective propidium iodide-stained nuclei (B) and after merging (C). (E) DP-1 all forms is located in the nucleus after merging (C and
F). Arrows show the protein in the nuclei (A, D) and arrowheads show the nuclei in same cell (B, C, E, F). Two arrows in the blastocyst in A show
trophoblast cells that would be presumptive TSC adjacent to the ICM and a diﬀerentiating trophoblast cell away from the ICM. In some areas, the
red intensity is very strong because many TSC pile up. No antibody controls are shown in Fig. 2. Inset shows the correct-sized band for DP-1 at 45
kDa in a Western blot developed from TSC lysates.
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that mycC phospho is detected in the nucleus from the second
cell cycle at the 2-cell stage and continues through the blasto-
cyst stage, suggesting that suﬃcient new zygotic RNA is pres-
ent to mediate mycC phospho-protein detection in the nucleus.
The all forms antibody for mycC detects mostly cytoplasmic
mycC in TSC and E3.5 blastocysts. Since all forms antibody
detects both phosphorylated and unphosphorylated subpopu-
lations of mycC, these data for all forms and phosphorylated
form taken together suggest the hypothesis that a small sub-
population of mycC is phosphorylated in the cytoplasm and
translocates to the nucleus under normal conditions in em-
bryos assayed ex vivo at all stages, and in TSC in vitro.
This hypothesis is supported by previous reports of myc
family proteins shuttling from the cytoplasm to the nucleus
in a possibly phosphorylation-dependent manner. (1) It has
been previously reported that mycC phospho thr58/ser62 can
be phosphorylated in the cytoplasm in somatic cells [38],
although a requisite nucleocytoplasmic shuttle was not re-
ported. (2) MycC has a deﬁned nuclear translocation signal
[13] and nuclear translocation can be regulated by phosphory-
lation [25] in early frog embryo divisions. In the ﬁrst 9 cleavage
divisions in frog, the majority of mycC is in the cytoplasm and
a minor population is detected in the nucleus after phosphor-
ylation. (3) A nucleocytoplasmic shuttle has previously not
been observed for mycC, but has been reported for other
myc family members, MondoA, Mad4, and Mlx, in mamma-
lian somatic cells [4,5,22,28,63]. We performed additional
experiments to clarify this lack of nuclear localization of mycC
all forms. We found that mycC all forms antibody detects
cytoplasmic mycC in the embryo and TSC, but almost exclu-
sively nuclear mycC in two other mammalian somatic cell
lines. Taken together, with the single correct sized protein de-
tected by Western blot analysis in TSC, these data suggest thatmycC all forms antibody is detecting mycC protein in the cyto-
plasm and that it translocates to the nucleus after phosphory-
lation. It is clear that nucleocytoplasmic shuttling equilibria
can be diﬀerent in embryogenesis, MAPK diphospho is de-
tected only in the nucleus in somatic cells, but is detected in
the cytoplasm in mouse embryos before and after implantation
[12,62]. Taken together the data suggest that phosphorylation
of mycC phospho thr58/ser62 probably occurs in the cyto-
plasm and leads to nuclear translocation in TSC, and early
mouse and frog embryos, and this may be a unique feature
for mycC in early reproductive tissue in mammals and frogs.
The max obligate heterodimer partner for the mycC is consti-
tutively expressed in the nucleus, suggesting that mycC need
only be phosphorylated and translocated from the cytoplasm
to activate new transcription.
The most essential activity of mycC is thought to occur in S
phase when it regulates a number of genes that are essential for
DNA synthesis [6]. However, mycC is expressed throughout
the cell cycle of proliferating cells [24,55], and detecting it in
all cells in the embryos and in TSC was anticipated.
Interestingly, another aspect of transcription factors, such as
mycC, and many kinases, such as MEK1, 2, is that the phos-
phorylated form is very highly expressed during M phase,
and has been suggested to have roles during structural interac-
tion with the cytoskeleton ([37, ] and references therein).
A previous study examined the expression of Rb (p110) all
forms protein and mRNA in preimplantation embryos. This
study incorrectly concluded that the high expression of Rb
all forms onset at the blastocyst stage would allow unfettered
proliferation at the early cell cycles simply due to low amounts
of Rb [30]. Our results using RT-PCR or cDNA array analysis
suggests that suﬃcient mRNA is present maternally and in
early embryonic divisions to sustain nuclear expression of
Rb and the presence of phospho Rb in nuclei at the two cell
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pressed in the earliest embryonic cell divisions, not that Rb is
not present until the blastocyst stage as previously reported
[30]. It follows that G1–S phase progression is a function of
phosphorylation and derepression of Rb function, not due to
the absence of Rb protein.
We have found that mycC phospho is regulated by phos-
phorylation of thr58/ser62 in blastocysts and TSC by growth
factors in a MAPK-dependent way, and mycC phospho is
rapidly lost in TSC and embryos in a stress-activated protein
kinase (SAPK/JNK)-dependent way (data not shown, manu-
scripts submitted [61,65]). It has been reported that mycC
phosphorylation at thr58/ser62 is primarily under the control
of MAPK and glycogen synthase kinase (GSK)-3 enzymes
[11,21,31,47,52,54,57]. In addition, in mycC phospho nuclear
sub-localization the negative aspects of mycC stability are
regulated by GSK-3. Our studies have not yet examined
GSK-3 regulation of mycC in embryos and TSC. Endoge-
nous MycC phospho did have some nuclear sub-localization
in TSC, but it is not clear how similar this is to the nuclear
sub-localization reported in somatic cells overexpressing
mycC [21]. In addition, SAPK/JNK is known to phosphory-
late mycC phospho at ser71, inducing apoptosis [41]. The net-
work of enzymes controlling diﬀerential mycC activity,
longevity, and sub-localization in embryos and TSC will be
a rich area for future study.
The data presented here suggest mycC phosphorylation and
Rb phosphorylation by a putative pathway for extracellular
control of proliferation by mitogen activated protein kinase/
extracellular receptor kinase (MAPK/ERK) that are known
to be expressed in early preimplantation development [Wang
et al., in press, Xie et al., in press, [29]]. MAPK can directly
phosphorylate retinoblastoma on the amino acid measured
in this report and associated with de-repression of prolifera-
tion. MAPK may directly phosphorylate mycC [23], but
MAPK also indirectly activates mycC by activating cyclin
transcription and subsequent cyclin-dependent kinase (CDK)
activation that results in phosphorylation of both mycC on
the amino acids tested in this study, and also on Rb
[11,19,44]. The activation of these pathways suggests that
growth factors and receptor tyrosine kinases (RTK) may pro-
vide proliferative control from the earliest cleavage divisions.
It is not what growth factors control mycC phospho and Rb
phospho during these early cleavage divisions. It is clear that
FGF can control proliferation in the early blastocyst [9,58]
and CSF-1 can control trophoblast cell proliferation as early
as the 8-cell stage [3]. Both FGF and CSF-1 activate mycC
phosphorylation in the early blastocyst in a MAPK-dependent
(U0126-sensitive) manner (Wang et al., manuscript in prepara-
tion). The early putative activation of MycC/max, de-repres-
sion of Rb, and activation of E2F/DP-1 would suggest that
endogenous growth factors, and/or growth factors provided
by the oviductal or uterine epithelium, may combine to main-
tain preimplantation cleavage divisions.
In summary, the data presented here suggest that prolifera-
tion control begins at the earliest cleavage divisions and sug-
gests that experiments should be performed to ascertain the
sum of inputs into embryonic and placental cells that mediate
proliferation control through pathways known to regulate pro-
liferation in adult somatic cells. The maternal expression of
many of these proliferation regulating gene products suggests
that post-implantation null lethals for proliferation will makegood candidates for the control or proliferation before
implantation.
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